The Effect of COVID-19 on Oncology Care for Adolescents and Young Adults in Latin America.

AYA COVID-19 global oncology

Journal

Journal of adolescent and young adult oncology
ISSN: 2156-535X
Titre abrégé: J Adolesc Young Adult Oncol
Pays: United States
ID NLM: 101543508

Informations de publication

Date de publication:
19 Mar 2024
Historique:
medline: 19 3 2024
pubmed: 19 3 2024
entrez: 19 3 2024
Statut: aheadofprint

Résumé

Children with cancer in low- and middle-income countries were disproportionately impacted by the COVID-19 pandemic, but little is known about how adolescents and young adults (AYAs) with cancer were affected. Sixty-seven physicians and nonphysician providers were interviewed about their experiences caring for AYAs with cancer in Latin America. Quotes related to the COVID-19 pandemic were identified and grouped into themes. Barriers from the COVID-19 pandemic included limited space, restrictions on travel, reduced funding, limited staff, limited services, and changes to treatment. However, improvements to care that arose from the COVID-19 pandemic included better access to distance learning and telemedicine.

Identifiants

pubmed: 38502817
doi: 10.1089/jayao.2023.0140
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Samantha L Wong (SL)

School of Medicine, University of California Davis, Sacramento, California, USA.

Emily Johnston (E)

Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Institute for Cancer Outcomes and Survivorship, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Nuria Rossell (N)

Independent Medical Anthropology Researcher, San Salvador, El Salvador.

Marcio Malogolowkin (M)

Division of Pediatric Hematology and Oncology, Davis School of Medicine, University of California, Sacramento, California, USA.

Ligia Rios (L)

Department of Pediatrics, Unidad de Oncología Pediátrica y del Adolescente, Hospital Nacional Edgardo Rebagliati Martins, Lima, Perú.

Wendy Gómez García (W)

Department of Oncology, Dr. Robert Reid Cabral Children's Hospital, Santo Domingo, Dominican Republic.
National Cancer Institute, INCART, Santo Domingo, Dominican Republic.

Federico Antillon-Klussmann (F)

Department of Hematology/Oncology, Unidad Nacional de Oncología Pediátrica, Guatemala City, Guatemala.
School of Medicine, Francisco Marroquín University, Guatemala City, Guatemala.

Ligia Fu (L)

Department of Pediatrics, Hospital Escuela, Tegucigalpa, Honduras.

Soad Fuentes-Alabi (S)

Department of Pediatric Oncology, National Program for Childhood Cancer, Ayudame a Vivir Foundation/National Children's Hospital Benjamin Bloom, San Salvador, El Salvador.

Karina Quintero Delgado (K)

Department of Pediatrics, Hospital del Niño Dr. José Renán Esquivel, Oncología, Panama City, Panama.

Daniel Ortiz Morales (D)

Department of Pediatrics, Hospital General de México, Mexico City, Mexico.

Carolina Rodriguez-Loza (C)

Department of Pediatric Oncology, National Program for Childhood Cancer, Ayudame a Vivir Foundation/National Children's Hospital Benjamin Bloom, San Salvador, El Salvador.

Ester Carolina Apesoa-Varano (EC)

Betty Irene Moore School of Nursing, University of California Davis, Sacramento, California, USA.

Paola Friedrich (P)

St. Jude Children's Research Hospital, Global Pediatric Medicine, Memphis, Tennessee, USA.

Elysia Alvarez (E)

Division of Pediatric Hematology and Oncology, Davis School of Medicine, University of California, Sacramento, California, USA.

Classifications MeSH